A $10.7 million National Institutes of Health grant has been approved in the hopes to develop a gonorrhea vaccine.
Sikora, an Oregon State University College of Pharmacy researcher,
will be a part of the study. She will work with the primary
investigator Ann Jerse with the Uniformed Services University of
Health Sciences and other collaborators from five more universities.
grant sets up the Gonorrhea Vaccine Cooperative Research Center,
which has a goal to develop a vaccine that can be used in clinical
trials in five years.
said researchers are excited to have been awarded the grant so their
research can be expanded to include the development of a vaccine
against a disease that still plagues humanity these days. She said it
allows her students and lab personnel to engage with well-known
gonorrhea researchers in the U.S.
Centers for Disease Control and Prevention has labeled the bacteria
Neisseria gonorrhoeae are superbug because it’s been resistant to
every class of antibiotic. A vaccine is critical is getting control
over the STD, which infects 78 million new people every year. If left
untreated, the disease can cause a host of health problems for men
Emory University, Duke University, the University of North Carolina, the University of New Mexico and the University of Virginia are also participating in the research.
Here’s what we've been up to recently.
The common and the first thought on people suffering from genital warts would surely be "How to Get Rid of Genital Warts" and thought is quite valid one. While few cases have visible genital warts that are not only irritating to the bearer but also appear repulsive, others are just invisibly unpleasant.